Found 90 articles
Exo Therapeutics Launches with $25 Million Series A Financing to Unlock Intractable Drug Targets with Exosites
Exo Therapeutics , Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion of a $25 million Series A financing. Investors in the round included Newpath Partners, Novartis Ventur
Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage company focused on pioneering the development of exosome-based therapeutics, today reported third quarter 2020 financial results and operational progress.
11/12/2020Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Exo (pronounced “echo”), a pioneering health information and devices company, closed a $40 million Series B+ funding round that will fund research and product development on a revolutionary handheld medical device and cloud-based workflow software platform.
ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).
5/22/2020Pharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.
Medical Imaging Startup makes key additions to commercialization and product teams
Company is Developing Drugs in the Field of Exoneural Biology to Address Cancer, Inflammatory Disease, and More [08-October-2019] CAMBRIDGE, Mass. , Oct. 8, 2019 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics . Founded in 2017 in Flagship Labs, Flagship's innovation foundry, Cygnal is the first co
Tyto Care Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
CB Insights today named Tyto Care to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world.
LetsGetChecked Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
LetsGetChecked recognized for achievements in home health testing
Deep Lens, Inc. Named to the 2019 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups
Deep Lens, Inc. recognized for achievements in Best Application of AI
OSF Ventures has joined a $35 million funding round to support a start-up that's developing a breakthrough handheld, AI ultrasound device that will allow health care providers to make critical, real-time diagnostic decisions.
Exo Imaging Emerges from Stealth Mode with $35M Series B Financing Round to Advance Development of the Exo Ultrasound Platform
Exo Imaging, Inc., a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications, announced a $35M Series B financing round.
Annual One-Day Event Hosted by System Biosciences and UCSF Features Experts in the Field
NeurExo Sciences and Henry Ford Health System Present Preclinical Data on Exosomes at ISEV2019 Annual Meeting
Exosomes demonstrate ability to enhance anti-tumor effect of platinum-based drugs and to ameliorate peripheral neuropathy
NewYork-Presbyterian and Columbia University Irving Medical Center Open New Sports Medicine and Performance Training Facility in Westchester
NewYork-Presbyterian, in collaboration with physicians from Columbia University Irving Medical Center, has launched a state-of-the-art sports medicine and performance training facility in Westchester County that gives patients and athletes access to some of the nation's top sports medicine doctors, therapists, and elite sports performance coaches–all at a single location.
Solera Health Appoints Dr. Andrey Ostrovsky as Chief Medical Officer and Vice President of Behavioral Health
Former Chief Medical Officer of the U.S. Medicaid Program to Expand Platform to Address Behavioral Health and Substance Use Disorders
Stem Cell Medicine Licenses Exosome Technology for Treating Autism From Ramot at Tel Aviv University
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple Sclerosis
DJO Announces New Global Headquarters in Dallas, Texas to Accommodate Growth and Accelerate Innovation
New Dallas focus will bring hundreds of new jobs to the area
Revenue and Profitability Growth Continue on Strength of Business Transformation